Literature DB >> 24671016

Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.

Natacha Levi-Marpillat1, Isabelle Macquin-Mavier2, Anne-Isabelle Tropeano3, Gianfranco Parati4, Patrick Maison1.   

Abstract

Increased blood pressure variability (BPV) contributes to end-organ damage, cardiovascular events and mortality associated with hypertension. In a cohort of 2780 hypertensive patients treated by either calcium channel blockers (CCBs), diuretics, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs) or β-blockers alone or in combination, we compared indices of short-term BPV according to the different treatments. Short-term BPV was calculated as the standard deviation (s.d.) of 24 h, daytime or nighttime systolic blood pressure and diastolic blood pressure (SBP and DBP). Short-term BPV was compared between patients treated with a given antihypertensive class of interest (alone or in combination) and those not treated with this class, after controlling for ambulatory average blood pressure, heart rate, age, gender, propensity scores and carotid-femoral pulse wave velocity. Patients treated with CCBs (n=1247) or diuretics (n=1486) alone, or in addition to other drugs had significant lower s.d. of 24-h SBP compared with those not treated with these classes (mean differences in s.d. -0.50±0.50 mm Hg, P=0.001 and -0.17±0.15 mm Hg, P=0.05, respectively). There was no significant difference regarding treatment with or without ARBs, ACEIs and β-blockers. The combinations of CCBs with diuretics or ARBs on top of other treatments resulted in a lower 24-h SBP variability (mean differences in s.d. -0.43±0.17 mm Hg, P=0.02 and -0.44±0.19 mm Hg, P=0.005 vs. other combination uses, respectively). Antihypertensive drug classes have differential effects on short-term BPV with a greater reduction in patients treated with CCBs and diuretics. The combinations of CCBs with diuretics may be the most efficient treatments in lowering BPV.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24671016     DOI: 10.1038/hr.2014.33

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  18 in total

1.  Correlation between short-term blood pressure variability and left-ventricular mass index: a meta-analysis.

Authors:  Jamie M Madden; Anne Marie O'Flynn; Anthony P Fitzgerald; Patricia M Kearney
Journal:  Hypertens Res       Date:  2015-11-19       Impact factor: 3.872

Review 2.  Is It Daily, Monthly, or Yearly Blood Pressure Variability that Enhances Cardiovascular Risk?

Authors:  Eamon Dolan; Eoin O'Brien
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

3.  Metoprolol has a similar therapeutic effect as amlodipine on BP lowering in hypertensive patients with obstructive sleep apnea.

Authors:  Jing Shi; Yue Yuan; Xianzhu Deng; Yujiao Pan; Meijiao He; Guangzhong Liu; Danghui Sun; Jiayu Wang; Wennan Wang; Yue Li
Journal:  Sleep Breath       Date:  2018-06-27       Impact factor: 2.816

4.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.

Authors:  A Concistrè; A Grillo; G La Torre; R Carretta; B Fabris; L Petramala; C Marinelli; A Rebellato; F Fallo; C Letizia
Journal:  Endocrine       Date:  2017-07-12       Impact factor: 3.633

Review 5.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

6.  Does reduced myocardial efficiency in systemic hypertensive-hypertrophy correlate with increased left-ventricular wall thickness?

Authors:  June-Chiew Han; Carolyn J Barrett; Andrew J Taberner; Denis S Loiselle
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

7.  Blood Pressure Ups and Downs Foreshadow Cerebral Microangiopathy.

Authors:  Costantino Iadecola; Neal S Parikh
Journal:  J Am Coll Cardiol       Date:  2020-05-19       Impact factor: 24.094

Review 8.  Blood pressure (BP) assessment-from BP level to BP variability.

Authors:  Janusz Feber; Mieczyslaw Litwin
Journal:  Pediatr Nephrol       Date:  2015-07-23       Impact factor: 3.714

9.  Comparison of cardiovascular response between patients on warfarin and hypertensive patients not on warfarin during dental extraction.

Authors:  Kazumasa Kubota; Eijiro Yamaga; Kaori Ueda; Masanao Inokoshi; Shunsuke Minakuchi
Journal:  Clin Oral Investig       Date:  2020-08-17       Impact factor: 3.573

Review 10.  Hypertension, Blood Pressure Variability, and Target Organ Lesion.

Authors:  Maria-Cláudia Irigoyen; Kátia De Angelis; Fernando Dos Santos; Daniela R Dartora; Bruno Rodrigues; Fernanda Marciano Consolim-Colombo
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.